APA (7th ed.) Citation

EN, C., D, A., K, S., E, J., M, H., H, Z., . . . J, J. (2025). Erratum to "Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease" [J Prev Alzheimers Dis 2025;12(4): 100082]. The journal of prevention of Alzheimer's disease, 12(7), 100217. https://doi.org/10.1016/j.tjpad.2025.100217

Chicago Style (17th ed.) Citation

EN, Cline, et al. "Erratum to "Biofluid Biomarker Changes Following Treatment with Sabirnetug (ACU193) in INTERCEPT-AD, a Phase 1 Trial in Early Alzheimer's Disease" [J Prev Alzheimers Dis 2025;12(4): 100082]." The Journal of Prevention of Alzheimer's Disease 12, no. 7 (2025): 100217. https://doi.org/10.1016/j.tjpad.2025.100217.

MLA (9th ed.) Citation

EN, Cline, et al. "Erratum to "Biofluid Biomarker Changes Following Treatment with Sabirnetug (ACU193) in INTERCEPT-AD, a Phase 1 Trial in Early Alzheimer's Disease" [J Prev Alzheimers Dis 2025;12(4): 100082]." The Journal of Prevention of Alzheimer's Disease, vol. 12, no. 7, 2025, p. 100217, https://doi.org/10.1016/j.tjpad.2025.100217.